
Sign up to save your podcasts
Or


Returning guest Sam Chapman and first-timer Jeremy Berke join host Ben Larson to talk about the recent Supreme Court decision to not hear a medical marijuana rescheduling case; the latest developments for Measure 109, a psilocybin mushroom ballot measure in Oregon; and the current state of marijuana industry investing and some of the mechanisms used to start and fund cannabis companies. Produced by Shea Gunther.
By MJToday MediaReturning guest Sam Chapman and first-timer Jeremy Berke join host Ben Larson to talk about the recent Supreme Court decision to not hear a medical marijuana rescheduling case; the latest developments for Measure 109, a psilocybin mushroom ballot measure in Oregon; and the current state of marijuana industry investing and some of the mechanisms used to start and fund cannabis companies. Produced by Shea Gunther.